JP2024517498A5 - - Google Patents

Info

Publication number
JP2024517498A5
JP2024517498A5 JP2023570456A JP2023570456A JP2024517498A5 JP 2024517498 A5 JP2024517498 A5 JP 2024517498A5 JP 2023570456 A JP2023570456 A JP 2023570456A JP 2023570456 A JP2023570456 A JP 2023570456A JP 2024517498 A5 JP2024517498 A5 JP 2024517498A5
Authority
JP
Japan
Prior art keywords
propanamide
formamide
hydroxyphenyl
halo
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023570456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517498A (ja
Filing date
Publication date
Priority claimed from EP21173972.7A external-priority patent/EP4089102A1/en
Application filed filed Critical
Publication of JP2024517498A publication Critical patent/JP2024517498A/ja
Publication of JP2024517498A5 publication Critical patent/JP2024517498A5/ja
Pending legal-status Critical Current

Links

JP2023570456A 2021-05-14 2022-05-13 化合物 Pending JP2024517498A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21173972.7A EP4089102A1 (en) 2021-05-14 2021-05-14 Modulators of sortilin activity
EP21173972.7 2021-05-14
PCT/EP2022/063049 WO2022238565A2 (en) 2021-05-14 2022-05-13 Compounds

Publications (2)

Publication Number Publication Date
JP2024517498A JP2024517498A (ja) 2024-04-22
JP2024517498A5 true JP2024517498A5 (cg-RX-API-DMAC7.html) 2025-04-22

Family

ID=75936805

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023570456A Pending JP2024517498A (ja) 2021-05-14 2022-05-13 化合物

Country Status (8)

Country Link
US (1) US20240294569A1 (cg-RX-API-DMAC7.html)
EP (2) EP4089102A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024517498A (cg-RX-API-DMAC7.html)
KR (1) KR20240007137A (cg-RX-API-DMAC7.html)
CN (1) CN117642416A (cg-RX-API-DMAC7.html)
AU (1) AU2022275011A1 (cg-RX-API-DMAC7.html)
CA (1) CA3217317A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022238565A2 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4471047A1 (en) * 2023-05-31 2024-12-04 Insusense ApS Modulators of sortilin activity
EP4361165A1 (en) * 2022-10-24 2024-05-01 Insusense ApS Modulators of sortilin activity
EP4428124A1 (en) * 2023-03-07 2024-09-11 Vesper Bio Aps Modulators of sortilin activity
EP4428121A1 (en) * 2023-03-07 2024-09-11 Vesper Bio Aps Modulators of sortilin activity
EP4428122A1 (en) * 2023-03-07 2024-09-11 Vesper Bio Aps Sortiline modulators
JP2026509275A (ja) * 2023-03-07 2026-03-17 ベスパー バイオ アーペーエス ソルチリン修飾剤
EP4719366A1 (en) 2023-05-26 2026-04-08 Bertram Wiedenmann Sortilin inhibitors for treatment of patients with functional neuroendocrine tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW217417B (cg-RX-API-DMAC7.html) * 1991-12-04 1993-12-11 Manyu Seiyaku Kk
SG176015A1 (en) 2009-05-13 2011-12-29 Gilead Sciences Inc Antiviral compounds
US9682967B2 (en) * 2013-01-28 2017-06-20 H. Lundbeck A/S N-substituted-5-substituted phthalamic acids as sortilin inhibitors
WO2015131100A1 (en) 2014-02-28 2015-09-03 The Scripps Research Institute Ligand-controlled c(sp3)-h arylation and olefination in synthesis of unnatural chiral alpha amino acids
US20160331746A1 (en) 2015-05-12 2016-11-17 University Of South Florida Sortilin-Binding Small Molecules for Increasing Glucose Uptake
CN110035775A (zh) * 2016-11-15 2019-07-19 学校法人东京理科大学 Ras蛋白分解诱导分子和药物组合物
CN109280075B (zh) * 2017-07-21 2022-05-20 四川海思科制药有限公司 肽酰胺类化合物及其制备方法和在医药上的用途

Similar Documents

Publication Publication Date Title
JP2024517678A5 (cg-RX-API-DMAC7.html)
JP2022185107A5 (cg-RX-API-DMAC7.html)
JP4405602B2 (ja) ヒストン脱アセチル化酵素阻害剤
JP2019518766A5 (cg-RX-API-DMAC7.html)
JP2011526594A5 (cg-RX-API-DMAC7.html)
EP2917190B1 (en) New benzene sulfonamide thiazole compounds
RU2315041C2 (ru) Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения
RU2005111975A (ru) Производные фенэтаноламина для лечения респираторных заболеваний
CA2418868A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
KR20150138214A (ko) (1s,4s,5s)-4-브로모-6-옥사비시클로[3.2.1]옥탄-7-온의 제조 방법
JP2024518555A5 (cg-RX-API-DMAC7.html)
RU2014113679A (ru) N-(2-амино-6,6-дифтор-4,4а,5,6,7,7а-гексагидро-циклопента[e][1,3]оксазин-4-ил)-фенил)-амиды в качестве ингибиторов бета-секретазы 1
JP2020502047A5 (cg-RX-API-DMAC7.html)
JP2020527173A5 (cg-RX-API-DMAC7.html)
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
RU2013130879A (ru) Производные оксазолилметилового эфира в качестве агонистов рецептора alx
JP2008508247A5 (cg-RX-API-DMAC7.html)
JP2015511232A5 (cg-RX-API-DMAC7.html)
CA2420568A1 (en) Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
JP2023550543A5 (cg-RX-API-DMAC7.html)
JP2019504090A (ja) ダサチニブの固体状態形態およびそれらの調製プロセス
JP2010526867A5 (cg-RX-API-DMAC7.html)
IL287159B1 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
JP2008508248A5 (cg-RX-API-DMAC7.html)